Daily News Podcast

Blood pressure meds cut cognitive impairment risk

Publish date: July 26, 2018

 

Hypertension meds slashed mild cognitive impairment risk by 19% in the SPRINT MIND study. Updated HIV guidelines recommend immediate treatment and three-drug therapy. Early antidepressant therapy after a heart attack delivers benefits years later. And HIV infection could double a patient’s risk of stroke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Renal denervation for hypertension rebounds
MDedge Endocrinology
In T2DM, healthy lifestyle lowers CVD risk, mortality
MDedge Endocrinology
Alirocumab’s benefit greater in diabetes patients: ODYSSEY Outcomes
MDedge Endocrinology
New hypertension guidelines would add 15.6 million new diagnoses
MDedge Endocrinology
AGA Clinical Practice Update: Statins are safe, effective, and important for most patients with liver disease and dyslipidemia
MDedge Endocrinology
CVD-REAL 2: Lower mortality, CV risks with SGLT-2i vs. DPP-4i treatment in T2DM
MDedge Endocrinology
Trial data suggest beneficial class effects of SGLT2 inhibitors, including dapagliflozin
MDedge Endocrinology
Omega-3 heart benefit: Just another fish tale?
MDedge Endocrinology
Diabetes, hypertension, smoking may raise risk for late-onset epilepsy
MDedge Endocrinology
Is fish oil’s heart benefit a fish tale?
MDedge Endocrinology